A common insulin signaling pathway across cancer and diabetes

(Vanderbilt University Medical Center) An oncology researcher has made an unexpected contribution to the understanding of type 2 diabetes. In results published in Science Advances, Patrick Hu, M.D., associate professor of medicine at Vanderbilt University Medical Center, found a protein that modulates a signaling pathway often targeted by cancer therapies is also required for insulin biogenesis.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news